This is the supplier profile page of Nanjing KeyGen Biotech. Co. Ltd., where buyers can explore products, connect directly with the supplier for pricing inquiries.
China
0
238 at Zhongyang road, Nanjing
Add Favorite
Report Supplier
Business Description
Nanjing KeyGen Biotech. Co. Ltd., founded in Nov. 2000, is a high-tech company, which focuses on R&D on innovative medicines and approaches to treating cancer. The main shareholder of KeyGen is Nanjing Medical Group Co., Ltd (NMG), one of top ten strongest Chinese pharmaceutical enterprises and one of the five largest Groups in Nanjing. We have set up a drug discovery platform with self-regulated intellectual property KeyGen Human Genomic Regulatory Database (HGRD) that is based on the cutting-edge genomic research and bioinformatics. The innovative anti-cancer decoy oligonucleotide drug KGCGS102 have got 4 Chinese patents, 3 international patents are in application process. Based on the core-technology of KeyGen during the anti-cancer new drug development, KeyGen has developed and marketed over 1400 reagents for life science research in the fields of cell biology, molecular biology, protein research.
Trade Capabilities
Business Terms
Preferred Payment Term:
Not specified
Preferred Trade Term:
Not specified
Port Of Loading:
Not specified
Accepted Currency:
USD
Trade Ability
Annual Revenue Amount:
Not specified
Numbers Of Employees:
Not specified
Avg Response Time:
-
